CA
Tema Oncology ETF (CANC)
NASDAQ·Financial Services·Asset Management
$40.80
-0.93%
Mkt Cap $117.66M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$211.60
Range $143.52 – $248.40
Implied Upside
+418.6%
Consensus $211.60 vs current $40.80